InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets

Shane Johnson, SVP and General Manager of Baymedica of InMed Pharmaceuticals INM, was a guest speaker at Benzinga’s All Access on June 17th, 2022. 

InMed Pharmaceuticals is an emerging global leader in the development, manufacturing and commercialization of rare cannabinoids and health and wellness consumer products. 

Watch the full interview here

Feature photo

Posted In: BiotechCannabisPenny StocksHealth CareMarketsGeneralBenzinga All AccessInMed Pharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...